Digital Necrosis: The Tip of the Iceberg! About 69 Cases
Journal Title: International Journal Of Medical Science And Clinical Research Studies - Year 2022, Vol 2, Issue 03
Abstract
Digital necrosis is a clinical manifestation of a general or locoregional pathology and represents the ultimate stage of distal ischemia (1). It is more likely to be the consequence of a macroangiopathy which can also sometimes be associated with a microangiopathy. The necrosis of fingers and toes may be caused by a great variety of diseases including collagen vascular diseases (systemic scleroderma…), arteriopathies, vasculitis, haemopathies, occupational diseases and many others (2).
Authors and Affiliations
Zakaryaa. S, Hali. F, Chiheb. S
Keywords
Related Articles
- EP ID EP713627
- DOI 10.47191/ijmscrs/v2-i3-08
- Views 23
- Downloads 0
Perioperative Management of the Facial Wounds with Insight of Scar Prevention
Human face is the front side of a head which functions most of all for individual identity. Global culture agrees that scarring on the face reducesattractiveness to the opposite sex; and it drives everyone with a wound...
Validity and Reliability Measurement of the Knowledge and AttitudeSurveyRegarding Pain Tool Vietnamese Version
Introduction:Knowledgeand attituderegarding pain management is one of the factors with the highest predictive value and it can explain 69% of nurses' s pain management practice[2]. Therefore, a standard tool...
Acute Portal Vein, Superior Mesenteric Vein and Splenic Vein Thrombosis Secondary to JAK2 V617 Mutation- A Case Report
Portal vein thrombosis (PVT) is a rare finding which usually occurs in association with local factors such as cirrhosis, malignancy, pancreatitis, intraabdominal infections or systemic hypercoagulable states. It may pres...
Melasma, A Guide of Management
Melasma management is frequently difficult, with many examples of inadequate remission and repeated relapses. Depending on the patient's features and clinical presentation, a multimodal treatment involving ph...
Study to Determine the Safety and Efficacy of Teneligliptin (20 Mg) in Naive Type 2 Diabetes Mellitus
Background: Teneligliptin is a novel, highly selective DPP-4 inhibitor with long half-life, approved in Japan (2012) and in Korea (2014) to treat patients of type 2 DM. It is characterized by a considerably rigid struct...